XML 23 R5.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Apr. 27, 2024
Apr. 29, 2023
Apr. 30, 2022
Revenue:      
Total revenue $ 192,970 $ 184,194 $ 106,477
Cost of revenue:      
Total cost of revenue 73,539 78,000 42,462
Gross profit 119,431 106,194 64,015
Operating expenses:      
Research and development 95,531 76,774 47,949
Selling, general and administrative 60,193 48,248 34,900
Impairment charges 765 2,407 3,134
Total operating expenses 156,489 127,429 85,983
Operating loss (37,058) (21,235) (21,968)
Other income (expense), net 14,313 3,321 (245)
Loss before income taxes (22,745) (17,914) (22,213)
Provision (benefit) for income taxes 5,624 (1,367) (37)
Net loss $ (28,369) $ (16,547) $ (22,176)
Net loss per share:      
Net loss per share, basic (in US dollars per share) $ (0.18) $ (0.11) $ (0.25)
Net loss per share, diluted (in US dollars per share) $ (0.18) $ (0.11) $ (0.25)
Weighted-average shares used in computing net loss per share:      
Weighted-average shares outstanding used in basic calculation (in shares) 155,091 146,556 88,398
Weighted-average shares used in computing net loss per share, diluted (in shares) 155,091 146,556 88,398
Product sales      
Revenue:      
Total revenue $ 145,048 $ 141,475 $ 73,721
Cost of revenue:      
Total cost of revenue 70,498 75,143 40,082
Product engineering services      
Revenue:      
Total revenue 19,898 10,780 7,741
Cost of revenue:      
Total cost of revenue 2,225 972 1,918
IP license      
Revenue:      
Total revenue 28,024 31,939 25,015
Cost of revenue:      
Total cost of revenue $ 816 $ 1,885 $ 462